NewLimit
Nicholas Bernstein is a Senior Data Scientist with a strong background in bioinformatics and computational biology. With experience in various research settings and companies, Nicholas has led projects involving genomic data analysis, deep learning methods, and experimental design for scientific objectives. Nicholas has a Bachelor of Arts degree in Neuroscience with minors in Mathematics and Chemistry from Colorado College.
NewLimit
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.